• Research/Demonstration Projects: Netherlands has an ongoing PrEP demonstration project, AMPrEP, for MSMs and transgender people.
  • Drug Registration: Currently, Gilead (the manufacturer of Truvada) has not applied to the Netherlands regulatory agency for a prevention indication. The European Medicines Agency is in the process of reviewing Truvada for PrEP. The Agency is responsible for the scientific evaluation of medicines developed by pharmaceutical companies for use in the European Union, but each member state will separately determine how, if at all, it might introduce PrEP.
  • Policy/Regulatory: There is no national policy or guidance at present.
  • Advocacy: The advocacy group PrEPnu is advocating for PrEP in the Netherlands and have a petition. If you’re a Netherlands advocate working on PrEP, building a campaign or seeking to share insights and experience, please send info here and PrEPWatch will post it.

News Spotlight